Tomasz Huzarski


Ontology type: schema:Person     


Person Info

NAME

Tomasz

SURNAME

Huzarski

Publications in SciGraph latest 50 shown

  • 2019-04 Age-specific risks of incident, contralateral and ipsilateral breast cancer among 1776 Polish BRCA1 mutation carriers in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-06 Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-04 Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study in BRITISH JOURNAL OF CANCER
  • 2018-04 Predictors of survival for breast cancer patients with a BRCA1 mutation in BREAST CANCER RESEARCH AND TREATMENT
  • 2018-01 Serum selenium levels predict survival after breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-12 Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2017-12 Meeting abstracts from the Annual Conference on Hereditary Cancers 2016 in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2017-05 Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer in NATURE GENETICS
  • 2016-04-27 Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer in NATURE COMMUNICATIONS
  • 2016-04 Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 in NATURE GENETICS
  • 2016-04 The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-01 Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-12 Iron as diagnostic marker of cancer in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2015-12 Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2015-12 Selenium as diagnostic marker of cancers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2015-12 Zinc as diagnostic marker of cancers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2015-12 Copper as diagnostic marker of cancers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2015-12 Magnesium as a diagnostic marker of cancer in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2015-12 Pathological complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2015-11 Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-06 Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-06 Germline RECQL mutations are associated with breast cancer susceptibility in NATURE GENETICS
  • 2015-04 Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer in NATURE GENETICS
  • 2014-09 Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-07 Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-04 Survival from breast cancer in patients with CHEK2 mutations in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-02 Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-12 Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families in MOLECULAR BIOLOGY REPORTS
  • 2013-10 Clinical characteristics of breast cancer in patients with an NBS1 mutation in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-06 A personalised approach to prostate cancer screening based on genotyping of risk founder alleles in BRITISH JOURNAL OF CANCER
  • 2013-02 Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-12 Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Impact of BRCA1 mutation on survival after early onset breast cancer in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Vitamins A, E and D and cancer risk in BRCA1 carriers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Zinc and breast cancer risk in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Folic acid and cancer risk in BRCA1 carriers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 CHEK2 mutations as markers for high risk of breast cancer in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Iron and breast cancer risk in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Selenium (Se) and breast cancer risk in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Why choose the treatment with cisplatin for BRCA1 breast cancers patients? in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Selenium (Se) and the risk of breast, ovarian and prostate cancers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 The risk of breast cancer in women with a CHEK2 mutation in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-12 Selenium and genotypes as marker of risk in BRCA1 mutation carriers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-08 Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer in BREAST CANCER RESEARCH
  • 2012-07 Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study in CANCER CAUSES & CONTROL
  • 2012-06 Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.107950.a", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.16753.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.458424.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17063.33", 
            "type": "Organization"
          }
        ], 
        "familyName": "Huzarski", 
        "givenName": "Tomasz", 
        "id": "sg:person.0766454475.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766454475.58"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:04", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_769.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0766454475.58'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0766454475.58'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0766454475.58'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0766454475.58'


     




    Preview window. Press ESC to close (or click here)


    ...